269 related articles for article (PubMed ID: 27522065)
41. Seroprevalence of hepatitis E virus among blood donors on Corsica, France, 2017.
Capai L; Hozé N; Chiaroni J; Gross S; Djoudi R; Charrel R; Izopet J; Bosseur F; Priet S; Cauchemez S; de Lamballerie X; Falchi A; Gallian P
Euro Surveill; 2020 Feb; 25(5):. PubMed ID: 32046820
[TBL] [Abstract][Full Text] [Related]
42. A nationwide retrospective study on prevalence of hepatitis E virus infection in Italian blood donors.
Spada E; Pupella S; Pisani G; Bruni R; Chionne P; Madonna E; Villano U; Simeoni M; Fabi S; Marano G; Marcantonio C; Pezzotti P; Ciccaglione AR; Liumbruno GM
Blood Transfus; 2018 Sep; 16(5):413-421. PubMed ID: 29757135
[TBL] [Abstract][Full Text] [Related]
43. Viral load and clinical manifestations of hepatitis E virus genotype 3 infections.
Lhomme S; Gallian P; Dimeglio C; Assal A; Abravanel F; Tiberghien P; Izopet J
J Viral Hepat; 2019 Sep; 26(9):1139-1142. PubMed ID: 31099059
[TBL] [Abstract][Full Text] [Related]
44. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.
Hewitt PE; Ijaz S; Brailsford SR; Brett R; Dicks S; Haywood B; Kennedy IT; Kitchen A; Patel P; Poh J; Russell K; Tettmar KI; Tossell J; Ushiro-Lumb I; Tedder RS
Lancet; 2014 Nov; 384(9956):1766-73. PubMed ID: 25078306
[TBL] [Abstract][Full Text] [Related]
45. Incidence of hepatitis E virus infection among blood donors in a high endemic area of Central Italy.
Marcantonio C; Pezzotti P; Bruni R; Taliani G; Chionne P; Madonna E; Villano U; Pisani G; Equestre M; Dell'Orso L; Ragone K; Ciccaglione AR; Spada E
J Viral Hepat; 2019 Apr; 26(4):506-512. PubMed ID: 30548124
[TBL] [Abstract][Full Text] [Related]
46. Hepatitis E virus infections in German blood donors: results of 8 years of screening, 2015 to 2022.
Plümers R; Dreier J; Knabbe C; Gömer A; Steinmann E; Todt D; Vollmer T
Euro Surveill; 2024 Jun; 29(24):. PubMed ID: 38873797
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011.
Vollmer T; Diekmann J; Eberhardt M; Knabbe C; Dreier J
Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608433
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of anti-HEV IgM among blood donors in Egypt.
Ibrahim EH; Abdelwahab SF; Nady S; Hashem M; Galal G; Sobhy M; Saleh AS; Shata MT
Egypt J Immunol; 2011; 18(2):47-58. PubMed ID: 23082470
[TBL] [Abstract][Full Text] [Related]
49. Serological and molecular studies on subclinical hepatitis E virus infection using periodic serum samples obtained from healthy individuals.
Mitsui T; Tsukamoto Y; Suzuki S; Yamazaki C; Masuko K; Tsuda F; Takahashi M; Tsatsralt-Od B; Nishizawa T; Okamoto H
J Med Virol; 2005 Aug; 76(4):526-33. PubMed ID: 15977233
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis E virus blood donor NAT screening: as much as possible or as much as needed?
Vollmer T; Diekmann J; Knabbe C; Dreier J
Transfusion; 2019 Feb; 59(2):612-622. PubMed ID: 30548866
[TBL] [Abstract][Full Text] [Related]
51. High prevalence of hepatitis E virus antibodies among blood donors in Southern Brazil.
Passos-Castilho AM; de Sena A; Geraldo A; Spada C; Granato CF
J Med Virol; 2016 Feb; 88(2):361-4. PubMed ID: 26211918
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of hepatitis E virus infection among blood donors in mainland China: a meta-analysis.
Zhang L; Jiao S; Yang Z; Xu L; Liu L; Feng Q; Zhang X; Hou Y; He S; Saldanha J; Wang S; Wang B
Transfusion; 2017 Feb; 57(2):248-257. PubMed ID: 28035774
[TBL] [Abstract][Full Text] [Related]
53. A nationwide survey for hepatitis E virus prevalence in Japanese blood donors with elevated alanine aminotransferase.
Sakata H; Matsubayashi K; Takeda H; Sato S; Kato T; Hino S; Tadokoro K; Ikeda H
Transfusion; 2008 Dec; 48(12):2568-76. PubMed ID: 18774966
[TBL] [Abstract][Full Text] [Related]
54. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients.
Rossi-Tamisier M; Moal V; Gerolami R; Colson P
J Clin Virol; 2013 Jan; 56(1):62-4. PubMed ID: 23089569
[TBL] [Abstract][Full Text] [Related]
55. A nationwide survey of hepatitis E virus infection in the general population of Japan.
Takahashi M; Tamura K; Hoshino Y; Nagashima S; Yazaki Y; Mizuo H; Iwamoto S; Okayama M; Nakamura Y; Kajii E; Okamoto H
J Med Virol; 2010 Feb; 82(2):271-81. PubMed ID: 20029817
[TBL] [Abstract][Full Text] [Related]
56. Long-term HEV carriers without antibody seroconversion among eligible immunocompetent blood donors.
Wen GP; Chen CR; Song XY; Tang ZM; Ji WF; Wang SL; Zhang K; Zhang J; Ou SH; Zheng ZZ; Xia NS
Emerg Microbes Infect; 2018 Jul; 7(1):125. PubMed ID: 29977038
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis E virus infections in blood donors, France.
Gallian P; Lhomme S; Piquet Y; Sauné K; Abravanel F; Assal A; Tiberghien P; Izopet J
Emerg Infect Dis; 2014 Nov; 20(11):1914-7. PubMed ID: 25340881
[TBL] [Abstract][Full Text] [Related]
58. Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017‒2020.
Bes M; Costafreda MI; Riveiro-Barciela M; Piron M; Rico A; Quer J; Puig L; Sauleda S
Emerg Infect Dis; 2022 Jan; 28(1):157-165. PubMed ID: 34932460
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment.
Hoad VC; Seed CR; Fryk JJ; Harley R; Flower RLP; Hogema BM; Kiely P; Faddy HM
Vox Sang; 2017 Oct; 112(7):614-621. PubMed ID: 28833229
[TBL] [Abstract][Full Text] [Related]
60. A Public Health initiative on hepatitis E virus epidemiology, safety and control in Portugal--study protocol.
Mesquita JR; Myrmel M; Stene-Johansen K; Øverbø J; Nascimento MS
BMC Infect Dis; 2016 Jan; 16():17. PubMed ID: 26774897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
